Table GPS-15. Last year prevalence of drug use among youngest adults (aged 15 to 24) in nationwide surveys among the general population

Country – Geographical Area 

Year

Ref.

Age range youngest adults

Sample size 15-24

Cannabis (%)

Cocaine (%) (1)

Amphetamines (%) (2)

Ecstasy (%)
(3)

LSD (%)

Belgium 

Flemish Community (Brussels excluded)

 

1994

(1)

 

 

 

 

 

 

 

French-speaking Community

 

1996-97

(2)

18-24

 

 

 

 

 

 

French-speaking Community

 

1998-99

(3)

18-24

 

 

 

 

 

 

French-speaking Community

 

2000

(4)

18-24

 

 

 

 

 

 

National

 

2001

(5)

15-24

1152

 

 

 

 

 

Czech Republic 

National

 

2002

(1)

18-24

389

32.0

 

3.5

10.8

3.5

National

 

2004

(2)

18-24

586

28.2

0.4

2.2

12.0

1.3

Denmark 

National

 

1990

(1)

 

 

 

 

 

 

 

National

 

1994

(2)

 

 

 

 

 

 

 

National

 

2000

(3)

16-24

1754

19.7

2.7

5.6

2.2

0.6

Germany 

East Germany

 

1990

(1)

 

 

 

 

 

 

 

Western Germany

 

1990

(2)

 

 

 

 

 

 

 

Old and New Länder

 

1995

(3)

18-24

 

15.7

2.4

3.1

4.2

 

Old and New Länder

 

1997

(4)

18-24

 

11.9

1.8

1.8

2.8

 

National

 

2000

(5)

18-24

963

21.1

2.4

2.7

2.9

1.0

National

 

2003

(6)

18-24

1891

22.1

2.1

3.1

2.1

0.6

Estonia 

National

 

1998

(1)

18-24

 

7.0

1.0

3.0

1.0

1.0

National

 

2003

(2)

15-24

329

18.2

1.8

5.5

6.1

1.5

Greece 

Athens

 

1993

(1)

 

 

 

 

 

 

 

National (except Aegean and Ionian Islands)

 

1998

(2)

15-24

1373

10.3

1.1

0.3

0.5

 

National (except Aegean and Ionian Islands)

 

2004

(3)

15-24

1785

3.6

0.2

0.1

0.3

0.2

Spain 

National

 

1995

(1)

 

 

 

 

 

 

 

National

 

1997

(2)

15-24

 

18.1

2.8

2.1

2.6

 

National

 

1999

(3)

15-24

 

16.6

3.3

1.8

2.2

 

National

 

2001

(4)

15-24

3368

21.0

4.4

2.6

4.6

 

National

 

2003

(5)

15-24

2327

24.0

4.8

2.1

4.0

 

France 

National

 

1992

(1)

 

 

 

 

 

 

 

Metropolitan France

 

1995

(2)

18-24

 

18.7

0.0

1.3

 

 

National

 

1999

(3)

15-24

 

20.3

0.6

0.0

0.8

0.0

National

 

2000

(4)

15-24

 

24.6

0.7

0.6

0.9

0.9

Metropolitan France

 

2002

(5)

15-24

345

28.0

0.9

0.0

1.1

0.6

Ireland 

National

 

1998

(1)

 

 

 

 

 

 

 

National

 

1998

(2)

18-24

 

26.0

3.4

8.8

8.1

5.1

National

 

2000

(3)

 

 

 

 

 

 

 

National

 

2002-03

(4)

15-24

 

11.0

2.7

1.2

2.8

0.2

Italy 

National

 

2001

(1)

15-24

 

11.5

1.8

0.1

0.1

0.0

National

 

2003

(2)

15-24

2112

16.7

2.5

0.6

0.8

1.0

Cyprus 

National

(4)

2003

(1)

15-24

420

18.6

0.5

 

3.8

 

Latvia 

National

 

2003

(1)

15-24

 

12.7

0.6

3.0

3.0

1.5

Lithuania 

National

 

2004

(1)

15-24

923

7.0

0.7

1.2

1.2

0.2

Luxembourg 

National

 

1998

(1)

15-24

 

 

 

 

 

 

Hungary 

National

 

2001

(1)

15-24

308

9.3

0.0

2.5

2.8

2.5

National

 

2003

(2)

18-24

943

13.3

1.0

3.1

4.2

1.1

Malta 

National

 

2001

(1)

 

 

 

 

 

 

 

Netherlands 

National

 

1997-98

(1)

15-24

 

14.3

1.6

1.1

2.2

 

National

 

2001

(2)

15-24

 

16.9

2.8

2.0

4.8

0.1

Austria 

National

 

2004

(1)

15-24

959

15.0

1.7

1.9

2.0

0.4

Poland 

National

 

2002

(1)

16-24

 

9.2

2.0

2.1

0.9

1.6

Portugal 

National

 

2001

(1)

15-24

3099

8.0

0.7

0.1

1.2

0.4

Slovakia 

National

 

2002

(1)

18-24

 

10.9

0.5

0.7

2.4

 

National

 

2004

(2)

15-24

307

11.4

0.0

0.7

3.3

 

Finland 

National

 

1992

(1)

 

 

 

 

 

 

 

National

 

1996

(2)

 

 

 

 

 

 

 

National

 

1998

(3)

 

 

9.5

 

0.6

0.6

 

National

 

2000

(4)

15-24

 

6.7

0.3

1.2

1.0

0.6

National

 

2002

(5)

15-24

614

10.7

0.8

2.1

2.0

0.3

National

 

2004

(6)

15-24

494

9.6

1.1

2.2

2.4

0.3

Sweden 

National

 

1994

(1)

16-24

146

 

 

 

 

 

National

 

1996

(2)

16-24

228

 

 

 

 

 

National

 

1998

(3)

16-24

244

2.4

0.0

0.0

0.0

 

National

 

2000

(4)

16-24

 

1.9

0.0

0.0

0.9

0.0

National

 

2004

(5)

16-24

1171

7.3

 

 

 

 

National

 

2005

(6)

16-24

4502

7.0

 

 

 

 

United Kingdom 

England and Wales

 

1994

(1)

16-24

1442

26.4

1.4

9.5

4.1

5.6

England and Wales

 

1996

(2)

16-24

1475

26.0

1.4

11.8

6.6

4.5

England and Wales

 

1998

(3)

16-24

1295

28.2

3.2

9.9

5.1

3.2

England and Wales

 

2000

(4)

16-24

1517

27.0

5.4

6.2

5.6

2.5

England and Wales

 

2001-02

(5)

16-24

4057

26.9

4.9

5.0

6.8

1.2

England and Wales

 

2002-03

(6)

16-24

4292

25.8

4.7

3.7

5.4

0.8

England and Wales

 

2003-04

(7)

16-24

5429

24.8

5.0

4.0

5.3

0.8

England and Wales

 

2004-05

(8)

16-24

6287

23.5

4.9

3.3

4.8

0.5

Northern Ireland

 

2002-03

(9)

15-24

 

12.1

1.4

2.0

4.8

0.2

Scotland

 

2003

(10)

16-24

619

23.1

5.1

3.0

5.2

0.3

United Kingdom

 

2004

(11)

 

 

24.3

4.9

3.8

5.3

0.8

Bulgaria 

National

 

2005

(1)

18-24

173

6.6

1.6

2.2

2.7

1.1

Romania 

National

 

2004

(1)

15-24

 

 

 

 

 

 

Norway 

National

 

1999

(1)

15-24

 

 

 

 

 

 

National

 

2004

(2)

15-24

645

13.1

1.4

2.5

1.3

0.3

Notes:

(1) Cocaine in any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamines and ecstasy, for Denmark National 1994: hard drugs.

(3) For Spain: ecstasy and other designer drugs.

(4) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school surveys results. A new survey with a bigger sample was conducted in 2005.

This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.

For methods of each survey presented in this table, see Table GPS-1 part (ii).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.

Data filter | gpstab16-en.xml